| scholarly article | Q13442814 |
| P50 | author | Hidetaka Uramoto | Q92854230 |
| Takeshi Hanagiri | Q110679760 | ||
| P2093 | author name string | Tsunehiro Oyama | |
| Masaru Morita | |||
| Kosei Yasumoto | |||
| Kenji Sugio | |||
| Shoji Nakata | |||
| P2860 | cites work | Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression | Q24291194 |
| Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis | Q24292072 | ||
| WNT7a induces E-cadherin in lung cancer cells | Q24317695 | ||
| The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers | Q24321912 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia | Q28216984 | ||
| Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
| How many tumor suppressor genes are involved in human lung carcinogenesis? | Q33699741 | ||
| DNA hypermethylation in tumorigenesis: epigenetics joins genetics | Q33870798 | ||
| Molecular and genetic aspects of lung cancer | Q33891465 | ||
| Molecular genetic abnormalities in the pathogenesis of human lung cancer | Q34249055 | ||
| Reactivating the expression of methylation silenced genes in human cancer | Q34770617 | ||
| Inactivation of the E-cadherin-mediated cell adhesion system in human cancers | Q35753235 | ||
| K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer | Q36420159 | ||
| Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens | Q36550875 | ||
| Cancer and the FRA3B/FHIT fragile locus: it's a HIT | Q36648921 | ||
| Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma | Q38481338 | ||
| Frequent aberrant methylation of p16INK4a in primary rat lung tumors | Q40021115 | ||
| Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. | Q40515553 | ||
| Induction of DNA methylation and gene silencing by short interfering RNAs in human cells | Q40525501 | ||
| Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung | Q44961920 | ||
| Expression of deltaNp73 predicts poor prognosis in lung cancer | Q45122006 | ||
| Antisense MBD2 gene therapy inhibits tumorigenesis | Q45887897 | ||
| Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia | Q47835975 | ||
| Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma | Q50944026 | ||
| DNA methylation and expression of p16(INK4A) gene in pulmonary adenocarcinoma and anthracosis in background lung. | Q53416798 | ||
| Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. | Q54765745 | ||
| Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers. | Q55383295 | ||
| Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas | Q57890923 | ||
| Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon | Q72781919 | ||
| Prognostic impact of telomerase activity in non-small cell lung cancers | Q73181191 | ||
| Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience | Q74099120 | ||
| Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry | Q77580030 | ||
| Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma | Q78892631 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung carcinoma | Q18556110 |
| P304 | page(s) | 2190-2199 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance | |
| P478 | volume | 106 |
| Q53559080 | Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. |
| Q35068319 | Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC). |
| Q34295621 | Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer |
| Q34103461 | Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis |
| Q28472991 | Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis |
| Q30494942 | DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type |
| Q34133706 | DNA methylation of cancer genome. |
| Q28386334 | DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update |
| Q37997493 | Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis |
| Q33874587 | Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas |
| Q26996766 | Epigenetics of lung cancer |
| Q39771185 | Fhit regulates invasion of lung tumor cells |
| Q28385454 | Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma |
| Q35643951 | Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases |
| Q39084419 | High pesticide exposure events and DNA methylation among pesticide applicators in the agricultural health study |
| Q39785520 | Infrequently methylated event at sites -181 to -9 within the 5' CpG island of E-cadherin in non-small cell lung cancer |
| Q39709698 | Insights into the role of DNA methylation in disease through the use of mouse models |
| Q91980450 | Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter |
| Q35160337 | Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients |
| Q36217021 | Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients |
| Q37963519 | Molecular changes in smoking-related lung cancer |
| Q45857727 | Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer |
| Q33759917 | Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination |
| Q42254406 | Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection |
| Q28253632 | Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer |
| Q34513567 | Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis |
| Q51633333 | RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. |
| Q53048458 | Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications. |
| Q38002967 | Targeting epigenetic mediators of gene expression in thoracic malignancies. |
| Q34785439 | The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis |
| Q28068822 | The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review |
| Q41252193 | The clinicopathological significance and potential drug target of E-cadherin in NSCLC. |
| Q36500848 | The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review |
| Q34571504 | The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis |
| Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
| Q34029138 | Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma |
| Q55427539 | [Advances of DNA methylation in early diagnosis of lung cancer]. |
Search more.